Celula Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Investors
-
1
Celula General Information
Description
Provider of diagnostic testing services focused on enhancing the accuracy of disease diagnosis. The company specializes in improving the diagnostic accuracy of major women's diseases, specifically in gynecologic cancers and non-invasive prenatal diagnosis, helping healthcare professionals by offering cost-effective diagnostic resolutions.
Contact Information
Website
www.celula-inc.com(Operating Subsidiary)
Corporate Office
- 11011 Torreyana Road
- Suite 200
- San Diego, CA 92121
- United States
Corporate Office
- 11011 Torreyana Road
- Suite 200
- San Diego, CA 92121
- United States
Celula Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Jan-2016 | Completed | Generating Revenue | |||
| 8. Debt - General | 31-Mar-2015 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 02-Apr-2014 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 30-Jun-2011 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 18-May-2010 | Completed | Generating Revenue | |||
| 4. Grant | 22-Sep-2008 | Completed | Generating Revenue | |||
| 3. Early Stage VC | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | Completed | Generating Revenue | ||||
| 1. University Spin-Out | Completed | Generating Revenue |
Celula Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | ||||||||
| Series A1 | 337,777 | $0.000100 | $1.1 | $1.1 | 1x | $1.1 | 0.47% | |
| Series A | 139,997 | $0.000100 | $1.1 | $1.1 | 1x | $1.1 | 0.2% |
Celula Comparisons
Industry
Financing
Details
Celula Competitors (11)
One of Celula’s 11 competitors is DiaCarta, a Venture Capital-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DiaCarta | Venture Capital-Backed | Hayward, CA | ||||
| Genuity Science | Formerly VC-backed | Dublin, Ireland | ||||
| DalCor Pharmaceuticals | Venture Capital-Backed | Montreal, Canada | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Personalis | Formerly VC-backed | Fremont, CA |
Celula Patents
Celula Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2864472-A1 | Materials and methods for processing cell populations | Inactive | 20-Jun-2012 | ||
| EP-2864472-A4 | Materials and methods for processing cell populations | Inactive | 20-Jun-2012 | ||
| WO-2013192342-A1 | Materials and methods for processing cell populations | Inactive | 20-Jun-2012 | ||
| WO-2013010134-A2 | Systems, apparatus and methods for biochemical analysis | Inactive | 14-Jul-2011 | ||
| WO-2013010134-A3 | Systems, apparatus and methods for biochemical analysis | Inactive | 14-Jul-2011 | B01L3/5027 |
Celula Signals
Celula Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | ||
| CHL Medical Partners | Venture Capital | Minority | ||
| Enterprise Partners Venture Capital | Venture Capital | Minority | ||
| Kaiser Permanente Ventures | Corporate Venture Capital | Minority | ||
| Skyline Ventures | Venture Capital | Minority |
Celula FAQs
-
When was Celula founded?
Celula was founded in 2005.
-
Where is Celula headquartered?
Celula is headquartered in San Diego, CA.
-
What is the size of Celula?
Celula has 11 total employees.
-
What industry is Celula in?
Celula’s primary industry is Laboratory Services (Healthcare).
-
Is Celula a private or public company?
Celula is a Private company.
-
What is Celula’s current revenue?
The current revenue for Celula is .
-
How much funding has Celula raised over time?
Celula has raised $50.2M.
-
Who are Celula’s investors?
ARCH Venture Partners, CHL Medical Partners, Enterprise Partners Venture Capital, Kaiser Permanente Ventures, and Skyline Ventures are 5 of 7 investors who have invested in Celula.
-
Who are Celula’s competitors?
DiaCarta, Genuity Science, DalCor Pharmaceuticals, BPS Bioscience, and Personalis are some of the 11 competitors of Celula.
-
When was Celula acquired?
Celula was acquired on 01-Jan-2016.
-
Who acquired Celula?
Celula was acquired by NeoSeq.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process